FDA Approved: TASCENSO ODT — Supplemental Application (Cycle Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application to add TASCENSO ODT (fingolimod lauryl sulfate) as an orally disintegrating tablet form, expanding fingolimod's approved…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• TASCENSO ODT (FINGOLIMOD LAURYL SULFATE)

Snippet

SUPPL AP for TASCENSO ODT (FINGOLIMOD LAURYL SULFATE)